When was SpeechVive founded?

SpeechVive was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Where is SpeechVive located?

SpeechVive is headquartered in Lafayette, United States.

How many employees does SpeechVive have?

As of Aug 31, 2026, the latest employee count at SpeechVive is 5.

Is SpeechVive a funded company?

SpeechVive is a funded company, having raised a total of $4.69M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 03, 2014.

When was the latest funding round of SpeechVive?

SpeechVive's latest funding was a $***** Series A round on Apr 10, 2020, with participation from 5 investors.

Where does SpeechVive rank among its competitors?

SpeechVive ranks 36th amongst 209 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Cala Health, which secured $50M in Apr, 2026.

Who are the top competitors of SpeechVive?

SpeechVive's top competitors include Ceribell, Empatica and Cala Health. Among them, Cala Health secured the most recent funding round in April, 2026.

SpeechVive - 2026 Company Profile, Team, Funding & Competitors

Company Details

Speechvive is a medical device manufacturing company that has made a device designed for people with Parkinson's disease who have low vocal volume. SpeechVive detects the patient's speech and plays background noise in their ear; when they talk. This triggers a reflex in their brains that causes them to speak more loudly and clearly, without even thinking about it. The noise automatically turns off when they stop talking. When the user is not speaking, the SpeechVive device turns off the background sound, which enhances the patient's ability to hear and communicate. Speechvive is a Class 1 device.

Website: speechvive.com
Social
Email ID: *****@speechvive.com

Key Metrics

Founded Year

2011

Location

Lafayette, United States

Stage

Series A

Total Funding

$4.69M in 6 rounds

Latest Funding Round

Series A, Apr 10, 2020, $*****

Investors

Elevate Ventures & 8 more

Ranked

36^th among 209 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

Ceribell & 234 more

View SpeechVive's full profile

SpeechVive has raised a total funding of $4.69M over 6 rounds. Its first funding round was on Apr 03, 2014. Its latest funding round was a Series A round on Apr 10, 2020 for $*****. 5 investors participated in its latest round. SpeechVive has 9 institutional investors.

Here is the list of recent funding rounds of SpeechVive:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 10, 2020	7977296	Series A	2376739	5230623	2482425	8987454
Aug 10, 2018	8812648	Series A	3113001	6575504	8395327	5467193
May 18, 2016	3340503	Grant (prize money)	2340725	2832507	9205307	NIH

Access funding benchmarks and valuations. Sign up today!

View details of SpeechVive's funding rounds and investors

The founders of SpeechVive is Jessica Huber. Steve Mogensen is the CEO of SpeechVive.

Here are the details of SpeechVive's key team members:

Jessica Huber: Founder of SpeechVive.
Contact Info: 1 email address

View details of SpeechVive's Founder profiles and Board Members

SpeechVive's employee count trend

SpeechVive has 5 employees as of Aug 26. Here is SpeechVive's employee count trend over the years:

Uncover SpeechVive's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SpeechVive include Ceribell, Empatica and Cala Health. Here is the list of Top 10 competitors of SpeechVive, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
2nd	Empatica 2011, Milano (Italy), Series B	Developer of a wrist band to monitor physiological signals	$30.9M	RA Capital Management, Sanofi Ventures & 5 others	66/100
3rd	Cala Health 2013, Stanford (United States), Series D	Developer of a wearable non-invasive neuromodulation device	$257M	Vertex Growth, Novartis & 29 others	63/100
4th	Beacon Biosignals 2019, Boston (United States), Series B	AI-based EEG analysis and diagnosis platform for healthcare providers	$141M	General Catalyst, Logos & 11 others	63/100
5th	Emotiv 2011, San Francisco (United States), Seed	Manufacturer of wireless EEG headsets and software solutions	$7.41M	Disney Accelerator, The Wells Investment & 3 others	58/100
6th	BrainScope 2006, Bethesda (United States), Series B	Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds	$62.2M	Maryland Venture Fund, Aon & 11 others	58/100
7th	BrainCo 2015, Somerville (United States), Series A	Provider of a prosthetic hand and EEG headband for brain signal	$292M	Walden International, IDG Capital & 10 others	58/100
8th	Cumulus Neuro 2015, Belfast (United Kingdom), Series A	AI and cloud-based brain physiology analysis tool for clinical trials	$19.6M	Par Equity, Innovate UK & 29 others	57/100
9th	Kernel 2016, Los Angeles (United States), Series C	Developer of multimodal brain measurement technology for neuromedicine	$158M	General Catalyst, Eldridge Industries & 3 others	57/100
10th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	56/100
36th	SpeechVive 2011, Lafayette (United States), Series A	Aid for helping Parkinson’s patient to communicate	$4.69M	Elevate Ventures, SideCar Angels & 7 others	38/100